MedPath

Efficacy of Autologous Fibrin Glue in Pterygium

Not Applicable
Completed
Conditions
Pterygium
Interventions
Other: Suture
Other: Autologous fibrin glue
Registration Number
NCT04151017
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

Pterygium is wing-shaped, vascular, fleshy growth that originates on the conjuntiva and that can spread to the corneal limbus and beyond The surgical exeresis with autologous conjunctival autograft technique is the treatment of choice. Commercially available fibrin glue has been used preferentially for graft fixation due to its benefits compared to sutures; However, its cost and the risk of inflammatory immune reaction limit the its use. There are few studies about autologous fibrin glue.

OBJECTIVE: To determine the efficacy of autologous fibrin glue preparation in patients undergoing pterygium resection surgery. To compare with autologous conjunctival graft fixation with suture.

This is a randomized clinical trial. Two patient groups will undergo pterygium excision surgery. Group 1 will have autologous conjunctival graft fixation with autologous fibrin glue and group 2 will have suture graft fixation using 10.0 mononylon. Early and late postoperative surgical results as well as complication rates will be analyzed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • nasal primary pterygium
Exclusion Criteria
  • relapsed pterygium
  • patients with a history of previous eye surgery
  • patients with glaucoma using hypotensive eye drops
  • eye surface diseases
  • eye allergy
  • diabetic patients,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SuturesSuture-
Autologous fibrin glueAutologous fibrin glue-
Primary Outcome Measures
NameTimeMethod
Pterygium Recurrence6 months

Recurrence in 6 months

Secondary Outcome Measures
NameTimeMethod
Graft EdemaPostoperative day 1, 7, 21 and 30

Graft edema (1-4).

Postoperative PainPostoperative day 1, 7, 21 and 30

Presence Pain measured by a five-point scale, in which 0 means absence of symptom; 1 means easily tolerable symptom; 2 means symptom causing some discomfort; 3 means symptom partially interfering with usual activities and 4 means symptom completely interfering with usual activities

Autograft RetractionPostoperative day 1, 7, 21 and 30

Graft detachment or retraction

Trial Locations

Locations (1)

Santa Casa de Misericórdia

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

© Copyright 2025. All Rights Reserved by MedPath